How past malaria exposure changes early immune protection before parasites reach the blood

Integrating human and non-human primate data to understand the acquisition of pre-erythrocytic immunity in the face of previous malaria exposure

['FUNDING_U01'] · OREGON HEALTH & SCIENCE UNIVERSITY · NIH-11325275

This project compares immune responses in people and monkeys to show how prior malaria infections change protection by vaccines that act before parasites enter the bloodstream.

Quick facts

Phase['FUNDING_U01']
Study typeNih_funding
SexAll
SponsorOREGON HEALTH & SCIENCE UNIVERSITY (nih funded)
Locations1 site (PORTLAND, UNITED STATES)
Trial IDNIH-11325275 on ClinicalTrials.gov

What this research studies

Researchers will compare vaccinated non-human primates that have had prior malaria infections with ones that have not, directly examining immune cells in the liver at single-cell detail. They will match those detailed primate tissue results with blood samples from people vaccinated in both malaria-endemic (for example, sub-Saharan Africa) and non-endemic regions. By integrating the two datasets, the team aims to find immune patterns linked to weaker vaccine protection in people who previously had malaria. Those patterns could point to ways to improve vaccines or vaccination schedules for people living in places where malaria is common.

Who could benefit from this research

Good fit: Ideal participants are people enrolled in pre-erythrocytic malaria vaccine trials, including those with prior malaria exposure in endemic regions and malaria-naïve volunteers in non-endemic regions.

Not a fit: People who are not at risk for malaria, who do not receive these vaccines, or whose health prevents vaccination may not gain direct benefit from this project.

Why it matters

Potential benefit: If successful, this work could help design vaccines or strategies that give better protection to people living in malaria-endemic areas.

How similar studies have performed: Previous animal and human work shows prior malaria alters vaccine responses, but combining primate liver tissue data with human blood samples at single-cell resolution is a new and more detailed approach.

Where this research is happening

PORTLAND, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.